Home Newsletters Human Immunology News PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical...

PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination

By
Justin.choi
-
0
PDS Biotechnology Corporation announced the reopening of recruitment in the National Cancer Institute-led Phase II clinical trial evaluating PDS0101 in combination with two investigational immune-modulating agents in advanced HPV cancers.
[PDS Biotechnology Corporation]

Sorry, but the selected Zotpress account can't be found.

Press Release

RELATED ARTICLES

Exit mobile version